Send this to a friend

Boston Scientific receives FDA approval for non-opioid painkiller

Boston Scientific announced Thursday it has received regulatory approval for a new treatment for chronic pain without the use of opioids.
The product, the Spectra WaveWriter Spinal Cord Stimulator System, is the first therapy product of its kind approved by the U.S. Food & Drug Administration, the Marlborough medical device company said.
Boston Scientific said the system works by sending low electrical pulses ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media